TRAF6 and hypertensive disorder: LGMN directly interacts with and promotes the degradation of tumor necrosis factor receptor-associated factor 6 (TRAF6) through chaperone-mediated autophagy, thereby inhibiting NF-κB activation and impairing regulatory T-cell (Treg) differentiation and function to prevent hypertension and its complications [72].